Sponsored by
Earlier this month, we announced a $50,000 grant to DNKO LLC for preclinical research on a treatment using heat sensitive liposomes combined with LITT for targeted drug delivery. We now have a brief webinar available on the project, as well as a donation fund set up to help get this treatment into human trials.